Oral progesterone for the treatment of menopausal symptoms a review of the clinical evidence
The purpose of this review is to examine the clinical efficacy of micronized progesterone (Prometrium), a natural, bio-identical hormone, and methoxyprogesterone acetate (MPA; Provera), a synthetic hormone, individually and comparatively, for the management of menopausal symptoms
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2014, 29 April 2014
|
Series: | Rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this review is to examine the clinical efficacy of micronized progesterone (Prometrium), a natural, bio-identical hormone, and methoxyprogesterone acetate (MPA; Provera), a synthetic hormone, individually and comparatively, for the management of menopausal symptoms |
---|---|
Item Description: | Title from PDF caption. - "CADTH Rapid Response Service." |
Physical Description: | 1 PDF file (16 pages) illustration |